Literature DB >> 3781707

Thymosin alpha 1 and thymosin beta 4 in serum: comparison of normal, cord, homosexual and AIDS serum.

P H Naylor, A Friedman-Kien, E Hersh, M Erdos, A L Goldstein.   

Abstract

Thymosin alpha 1 and thymosin beta 4 were first isolated from thymosin fr. 5 and have demonstrated biological activities on the immune system. They are chemically distinct and differ in their immunological activity profiles. The levels of thymosin alpha 1 and thymosin beta 4 were assessed by radioimmunoassay in the same serum samples. Normal thymosin alpha 1 levels were 670 +/- 163 pg/ml for males and 652 +/- 162 pg/ml for females. Normal thymosin beta 4 levels were 974 +/- 400 ng/ml for males and 889 +/- 345 ng/ml for females. No correlation between the levels of the peptides in serum from normal donors was observed. Although many samples of serum from neonates (cord blood), homosexuals and AIDS patients had elevated levels of one or both peptides, no correlation between the two peptides was found. Of potential significance is the observation that while thymosin alpha 1 and beta 4 are elevated in many individuals with AIDS (57 and 48% respectively), the individuals with AIDS related immune dysfunctions had predominantly elevated thymosin alpha 1 (54 vs 15%). These studies suggest that serum levels of the two peptides are modulated separately and that both are of potential value in defining the risk of individuals for developing AIDS.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3781707     DOI: 10.1016/0192-0561(86)90001-9

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  11 in total

1.  Distribution and biological activity ofβ-thymosins.

Authors:  M Mihelić; W Voelter
Journal:  Amino Acids       Date:  1994-02       Impact factor: 3.520

2.  Synthesis and apparent secretion of prothymosin alpha by different subpopulations of calf and rat thymocytes.

Authors:  F J Franco; C Diaz; M Barcia; P Arias; J Gomez-Marquez; F Soriano; E Mendez; M Freire
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

3.  Neopterin and alpha and beta interleukin-1 levels in sera of patients with human immunodeficiency virus infection.

Authors:  M M Reddy; M H Grieco
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

4.  Beta 2-microglobulin and neopterin: predictive markers for human immunodeficiency virus type 1 infection in children?

Authors:  M M Chan; J M Campos; S Josephs; N Rifai
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

Review 5.  Roles of thymosins in cancers and other organ systems.

Authors:  Changyi Chen; Min Li; Hui Yang; Hong Chai; William Fisher; Qizhi Yao
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

6.  Prothymosin alpha in human blood.

Authors:  C Panneerselvam; A A Haritos; J Caldarella; B L Horecker
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

7.  Elevated soluble CD8 levels in sera of human immunodeficiency virus-infected populations.

Authors:  M M Reddy; M Lange; M H Grieco
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

8.  Thymosin-alpha1 modulates dendritic cell differentiation and functional maturation from human peripheral blood CD14+ monocytes.

Authors:  Qizhi Yao; Linh X Doan; Rongxin Zhang; Uddalak Bharadwaj; Min Li; Changyi Chen
Journal:  Immunol Lett       Date:  2007-05-15       Impact factor: 3.685

9.  Interleukin-2-dependent control of disease development in spontaneously diabetic BB rats.

Authors:  J Zielasek; V Burkart; P Naylor; A Goldstein; U Kiesel; H Kolb
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

10.  Human immunodeficiency virus contains an epitope immunoreactive with thymosin alpha 1 and the 30-amino acid synthetic p17 group-specific antigen peptide HGP-30.

Authors:  P H Naylor; C W Naylor; M Badamchian; S Wada; A L Goldstein; S S Wang; D K Sun; A H Thornton; P S Sarin
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.